Literature DB >> 12930508

Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient.

Kimie Ohkubo1, Ichiro Watanabe, Yasuo Okumura, Takeshi Yamada, Riko Masaki, Tatsuya Kofune, Naohiro Oshikawa, Yuji Kasamaki, Satoshi Saito, Yukio Ozawa, Katsuo Kanmatsuse.   

Abstract

A 53-year-old man with an abnormal ECG was referred to the Nihon University School of Medicine. The 12-lead ECG showed right bundle branch block and saddleback-type ST elevation in leads V1-V3 (Brugada-type ECG). Signal-averaged ECG showed positive late potentials. Double ventricular extrastimuli (S1: 500 ms, S2: 250 ms, S3: 210 ms) induced VF. Amiodarone (200 mg/day) was administered for 6 months and programmed ventricular stimulation was repeated. VF was induced again by double ventricular stimuli (S1: 600 ms, S2: 240 ms, S3: 170 ms). Intravenous administration of class Ic antiarrhythmic drug, pilsicainide (1 mg/kg), augmented ST-T elevation in leads V1-V3, and visible ST-T alternans that was enhanced by atrial pacing was observed in leads V2 and V3. Visible ST-T wave alternans disappeared in 15 minutes. However, microvolt T wave alternans was present during atrial pacing at a rate of 70/min without visible ST-T alternans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930508     DOI: 10.1046/j.1460-9592.2003.00288.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome.

Authors:  Jeffrey M Fish; Charles Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2007-11-21

2.  Sodium channel blockers enhance the temporal QT interval variability in the right precordial leads in Brugada syndrome.

Authors:  Tetsuzou Kanemori; Hiroki Shimizu; Katsumi Oka; Yoshio Furukawa; Kenji Hiromoto; Takanao Mine; Tohru Masuyama; Mitsumasa Ohyanagi
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-01       Impact factor: 1.468

Review 3.  T-wave alternans: reviewing the clinical performance, understanding limitations, characterizing methodologies.

Authors:  Euler de Vilhena Garcia
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

4.  Role of sodium and calcium channel block in unmasking the Brugada syndrome.

Authors:  Jeffrey M Fish; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2004-07       Impact factor: 6.343

Review 5.  Brugada syndrome: recent advances and controversies.

Authors:  Charles Antzelevitch; Eyal Nof
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.